Authors: DEMOISSAC D FAINSINGER RL COLE J MEADWOOD K LEE E

Citation: D. Demoissac et al., HOME DISCHARGE CHARACTERISTICS OF PALLIATIVE CARE PATIENTS IN AN ACUTE-CARE HOSPITAL, Journal of palliative care, 14(3), 1998, pp. 124-124

Authors: DEMOISSAC D MUSTAPHA S GREENBERG AH KIRSHENBAUM LA

Citation: D. Demoissac et al., BCL-2 ACTIVATES THE TRANSCRIPTION FACTOR NF-KAPPA-B THROUGH THE DEGRADATION OF THE CYTOPLASMIC INHIBITOR I-KAPPA-B-ALPHA, The Journal of biological chemistry, 273(37), 1998, pp. 23946-23951

Authors: KIRSHENBAUM LA GREENBERG AH DEMOISSAC D

Citation: La. Kirshenbaum et al., BCL-2 ACTIVATES THE TRANSCRIPTION FACTOR NFKB THROUGH THE DEGRADATIONOF THE CYTOPLASMIC INHIBITOR IKB-ALPHA IN VENTRICULAR MYOCYTES, Circulation, 98(17), 1998, pp. 3895-3895

Authors: BLONSKI C DEMOISSAC D PERIE J SYGUSCH J

Citation: C. Blonski et al., INHIBITION OF RABBIT MUSCLE ALDOLASE BY PHOSPHORYLATED AROMATIC-COMPOUNDS, Biochemical journal, 323, 1997, pp. 71-77

Authors: KIRSHENBAUM LA DEMOISSAC D

Citation: La. Kirshenbaum et D. Demoissac, THE BCL-2 GENE-PRODUCT PREVENTS PROGRAMMED CELL-DEATH OF VENTRICULAR MYOCYTES, Circulation, 96(5), 1997, pp. 1580-1585